Biocryst Pharmaceuticals buy Cantor Fitzgerald
Start price
15.10.25
/
50%
€5.72
Target price
15.10.26
€22.38
Performance (%)
68.53%
Price
07.07.26
€9.64
Summary
This prediction is currently active. With a performance of 68.53% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 15.10.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 10.197% | 10.197% |
| iShares Core DAX® | 1,77 % | 3,45 % |
| iShares Nasdaq 100 | -3,50 % | 1,61 % |
| iShares Nikkei 225® | -4,94 % | 4,22 % |
| iShares S&P 500 | 0,30 % | 2,58 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by analysts at Cantor Fitzgerald from $24.00 to $26.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.79
30.06.26
30.06.26
€25.44
30.06.27
30.06.27
9.67%
07.07.26
07.07.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.44
29.04.25
29.04.25
€17.56
29.04.26
29.04.26
1.64%
30.04.26
30.04.26